Merit Medical Systems, Inc. logo

Merit Medical Systems, Inc. (MMSI)

Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
60. 65
-0.24
-0.39%
$
3.7B Market Cap
43.82 P/E Ratio
- Div Yield
653,882 Volume
3.32 Eps
$ 60.89
Previous Close
Add Transaction
Day Range
60.02 61.68
Year Range
59.74 96.74
Want to track MMSI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why Merit Medical (MMSI) is a Strong Growth Stock

Here's Why Merit Medical (MMSI) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Merit Medical Stock Rises Following FDA Nod for WRAPSODY Device

Merit Medical Stock Rises Following FDA Nod for WRAPSODY Device

MMSI announces FDA approval for the WRAPSODY Cell-Impermeable Endoprosthesis.

Zacks | 1 year ago
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term

Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
MMSI or WST: Which Is the Better Value Stock Right Now?

MMSI or WST: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Merit Medical (MMSI) or West Pharmaceutical Services (WST). But which of these two stocks presents investors with the better value opportunity right now?

Zacks | 1 year ago
MMSI Stock Down Despite Latest Positive Data From WRAPSODY WAVE Trial

MMSI Stock Down Despite Latest Positive Data From WRAPSODY WAVE Trial

The significant improvement in patency rates for AVG patients via Merit Medical's WRAPSODY device is expected to enhance patients' vascular access survival.

Zacks | 1 year ago
3 Reasons Why Growth Investors Shouldn't Overlook Merit Medical (MMSI)

3 Reasons Why Growth Investors Shouldn't Overlook Merit Medical (MMSI)

Merit Medical (MMSI) could produce exceptional returns because of its solid growth attributes.

Zacks | 1 year ago
Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?

Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?

MMSI shows strong growth momentum with a robust product portfolio and recent acquisitions, positioning itself well in competitive healthcare markets.

Zacks | 1 year ago
Merit Medical Systems, Inc. (MMSI) Hits Fresh High: Is There Still Room to Run?

Merit Medical Systems, Inc. (MMSI) Hits Fresh High: Is There Still Room to Run?

Merit Medical (MMSI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 1 year ago
Is Merit Medical (MMSI) a Solid Growth Stock? 3 Reasons to Think "Yes"

Is Merit Medical (MMSI) a Solid Growth Stock? 3 Reasons to Think "Yes"

Merit Medical (MMSI) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 1 year ago
Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term

Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
MMSI's Stock Declines Despite Q3 Earnings Beat, Higher Gross Margin

MMSI's Stock Declines Despite Q3 Earnings Beat, Higher Gross Margin

Merit Medical benefits from revenue growth in both segments and all its product categories within its Cardiovascular unit in the third quarter.

Zacks | 1 year ago
Merit Medical Systems, Inc. (MMSI) Q3 2024 Earnings Call Transcript

Merit Medical Systems, Inc. (MMSI) Q3 2024 Earnings Call Transcript

Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Brian Lloyd - Chief Legal Officer & Corporate Secretary Joe Wright - President Raul Parra - Chief Financial Officer Conference Call Participants John Young - Canaccord Jayson Bedford - Raymond James Jason Bednar - Piper Sandler David Rescott - R.W. Baird Mike Matson - Needham Craig Bijou - Bank of America Securities Jim Sidoti - Sidoti & Company Michael Petusky - Barrington Research Steve Lichtman - Oppenheimer Operator Good day, and thank you for standing by.

Seekingalpha | 1 year ago
Loading...
Load More